Private Equity

The Dallas-based asset manager taps veteran Rob O’Connor to lead a new platform, capitalizing on surging investor demand for liquidity in private credit.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

A strategic partnership with 5 Horizons Ventures accelerates Marvel Biosciences' novel drug, MB-204, into human trials for autism, Rett syndrome, and more.

PMGC Holdings touts major acquisitions and a promising biotech pipeline, but a look at its financials reveals a high-stakes bet on future growth.

RA Capital's major investment extends Karyopharm's runway, but future funding is now directly tied to the outcome of its pivotal endometrial cancer trial.

Goldman Sachs' strategic investment extends GeoWealth's Series C, signaling a major push to dominate the future of customized wealth management technology.

A new biotech spins out with a novel drug class aiming to provide healthier, more durable weight loss and combat cancer-related wasting syndrome.

Nearly a century old, NPF Investment Advisors launches an actively managed ETF, aiming to deliver tax efficiency and long-term growth to a new generation.

UK's Abselion opens a US base in Cambridge, MA, aiming to disrupt biologics R&D with its rapid Amperia protein quantification system.

With $336M in the bank and three autoimmune drugs advancing, Jade Biosciences lays out a fast-paced timeline for key clinical milestones in 2026 and 2027.

A new MMA league is letting fans and fighters buy in. With veteran leaders and a $5M equity raise, can the Global Fight League disrupt the octagon?

The diagnostics firm has 180 days to boost its market value after a Nasdaq warning, placing immense pressure on its turnaround and high-stakes biosensor plans.

With a $250M war chest and a powerhouse leader, Averin Capital's new SPAC is set to shake up the M&A landscape at the intersection of tech and health.

The logistics tech firm's latest acquisition aims to streamline drayage operations, promising relief for truckers and a smoother flow for global trade.

After 11 years, Tucker Donahue is GFG Capital's new CIO, a move signaling strategic continuity and a deeper commitment to client engagement.

Tequity Advisors hires ServiceNow pioneer Thomas Moewe, signaling a strategic shift toward deep operational expertise in the booming tech M&A advisory space.

The deal, backed by private equity, aims to streamline complex Medicaid billing, impacting both hospital finances and patient access to care.

The major CRO acquisition deepens Worldwide's oncology and FSP capabilities, signaling a strategic move in the consolidating clinical research market.

With strategic hires and a new focus, Cahill is building a transatlantic team to capture the booming data center and real estate finance market.

Influential proxy advisors ISS and Glass Lewis urge shareholders to approve the C$36.60 per share cash offer, framing it as a secure exit for investors.